Suppliers and packagers for falmina

falmina

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Novast Labs Ltd	FALMINA	ethinyl estradiol; levonorgestrel	TABLET;ORAL-28	090721	ANDA	Northstar Rx LLC	16714-359-01	1 BLISTER PACK in 1 PACKET (16714-359-01) / 1 KIT in 1 BLISTER PACK	2013-09-13
Novast Labs Ltd	FALMINA	ethinyl estradiol; levonorgestrel	TABLET;ORAL-28	090721	ANDA	Northstar Rx LLC	16714-359-02	1 BLISTER PACK in 1 CARTON (16714-359-02) / 1 KIT in 1 BLISTER PACK	2013-09-13
Novast Labs Ltd	FALMINA	ethinyl estradiol; levonorgestrel	TABLET;ORAL-28	090721	ANDA	Northstar Rx LLC	16714-359-03	3 BLISTER PACK in 1 CARTON (16714-359-03) / 1 KIT in 1 BLISTER PACK	2013-09-13

Suppliers for the Pharmaceutical Drug: Falmina

Last updated: July 27, 2025

Introduction

Falmina is a combination oral contraceptive, predominantly used for birth control. It contains ethinyl estradiol and desogestrel, ingredients that suppress ovulation and prevent pregnancy. As a prescription medication, the supply chain for Falmina involves a complex network of pharmaceutical manufacturers, wholesalers, and distributors. This article provides an in-depth analysis of suppliers involved in producing, distributing, and maintaining the availability of Falmina globally, highlighting key players, regulatory considerations, and market dynamics.

Understanding Falmina's Composition and Manufacturing

Falmina’s active ingredients—ethinyl estradiol and desogestrel—are well-established synthetic hormones with extensive production histories. The manufacturing process of such hormonal drugs requires adherence to stringent quality standards dictated by regulatory agencies like the FDA (U.S. Food and Drug Administration) and EMA (European Medicines Agency).

Key manufacturing components include:

• Active Pharmaceutical Ingredient (API) Suppliers: Provide high-purity ethinyl estradiol and desogestrel.
• Formulation and Packaging: Final drug product manufacturing involves blending APIs with excipients, filling into blister packs, and packaging.

Major pharmaceutical companies specialize in the synthesis of these hormones and supply APIs to licensed drug manufacturers globally.

Primary API Suppliers for Ethinyl Estradiol and Desogestrel

1. Major API Manufacturers

The supply of active ingredients for Falmina hinges on a handful of global API producers:

• Hetero Labs Limited (India): A leading supplier of hormonal APIs, including ethinyl estradiol and desogestrel, with extensive manufacturing capacity and compliance with international standards.

• Mitsubishi Tanabe Pharma Corporation (Japan): Known for high-quality APIs, including synthetic hormones used in contraceptives.

• Famar Healthcare Services (Greece): Provides APIs for hormonal contraceptives, with robust manufacturing processes conforming to cGMP standards.

• Zhejiang Taizhou Wangchun Pharmaceutical (China): Supplies ethynyl estradiol and desogestrel, increasingly prominent in the global market.

2. Regional API Suppliers

• India: Houses a significant number of API suppliers due to cost advantages and large production capacity, including sectors specializing in steroid hormones.

• China: A growing hub for hormonal API manufacturing, with increasing quality standards and export volumes.

• Europe and Japan: Generally focus on high-quality, high-value APIs suitable for regulated markets.

3. Regulatory Compliance and Certification

Suppliers must comply with Good Manufacturing Practices (GMP), have quality certifications such as ISO 9001, and often undergo audits by clients to ensure compliance with regulatory standards.

Manufacturers of the Final Falmina Formulation

The final formulation of Falmina is typically produced by licensed pharmaceutical companies that source APIs from reliable suppliers. Known manufacturers include:

• Gedeon Richter (Hungary): An established producer of contraceptive pills, manufacturing various generic oral contraceptives, including formulations similar to Falmina.

• Sandoz (Novartis): Offers generic contraceptive options, sourcing APIs from global suppliers.

• Teva Pharmaceutical Industries (Israel): A major generics manufacturer with extensive contraceptive development capacity.

• Biocon (India): Produces hormonal contraceptives and components.

Contract Manufacturing Organizations (CMOs)

Multiple pharmaceutical companies outsource production to CMOs, which provide specialized formulating, filling, and packaging services, ensuring scalability and compliance.

Distribution and Wholesaler Networks

Post-manufacturing, Falmina’s distribution involves a network of licensed pharmaceutical distributors, wholesalers, and pharmacies. The supply chain must comply with national regulations, ensuring drug security, quality maintenance, and traceability.

• Global Distributors: Companies such as McKesson, AmerisourceBergen, and Cardinal Health manage distribution for many countries, facilitating bulk procurement by healthcare providers.

• Regional Distributors: National or regional firms specialize in the distribution within specific legal jurisdictions, ensuring compliance with local regulations.

Regulatory and Market Considerations

The distribution and manufacturing of Falmina depend heavily on regulatory approvals. Suppliers must navigate complex registration processes in each target market, including the European Union, United States, Latin America, Asia, and Africa. Licensing agreements and patent laws influence the sourcing and pricing of APIs and finished products.

For instance, in the U.S., generics manufacturers must obtain FDA approval via ANDA (Abbreviated New Drug Application), verifying bioequivalence and manufacturing standards.

Market Dynamics and Commercial Factors

• Price competition: Indian and Chinese APIs often offer cost advantages, influencing global procurement strategies.

• Supply chain disruptions: Fluctuations in raw material availability, geopolitical issues, or regulatory delays can impact supply consistency.

• Quality assurance: Stringent quality requirements necessitate continuous oversight of suppliers, especially when sourcing APIs from emerging markets.

Key Players Summary

Entity Type	Notable Names	Role in Falmina Supply Chain	Location
API Suppliers	Hetero Labs, Mitsubishi Tanabe Pharma, Zhejiang Taizhou Wangchun	Provide ethinyl estradiol and desogestrel	India, Japan, China
OEM Manufacturers	Gedeon Richter, Sandoz, Teva	Final formulation, packaging	Europe, Middle East, Asia
Distributors	McKesson, Cardinal Health, regional firms	Supply to pharmacies and clinics	Global

Future Outlook

The global contraceptive market’s growth, driven by expanding female workforce participation and family planning initiatives, promises sustained demand for Falmina. Supply chain resilience will depend on diversified API sourcing and adherence to evolving regulatory standards.

Advancements in API manufacturing, including sustainable and cost-effective synthesis methods, will continue to influence supplier dynamics. Additionally, increasing regulatory scrutiny on API quality and traceability may alter procurement strategies, favoring established suppliers with proven compliance histories.

---

Key Takeaways

• API sourcing remains the backbone: High-quality API suppliers in India, China, Japan, and Europe provide ethinyl estradiol and desogestrel essential for Falmina production.

• Manufacturing is highly regulated: Compliance with cGMP and international standards ensures safety, efficacy, and market access.

• Distribution networks are extensive: Global and regional distributors facilitate reliable supply but are susceptible to geopolitical and logistical disruptions.

• Market growth will shape supplier strategies: Increasing demand for contraceptives underscores the importance of diversified, compliant sourcing to ensure continuous supply.

• Regulatory compliance is decisive: Suppliers with proven regulatory compliance and certifications maintain competitive advantages.

---

Frequently Asked Questions (FAQs)

1. Who are the main API suppliers for the hormones used in Falmina?
Major API producers include Hetero Labs (India), Mitsubishi Tanabe Pharma (Japan), Zhejiang Taizhou Wangchun Pharmaceutical (China), and Famar Healthcare Services (Greece). These companies supply high-purity ethinyl estradiol and desogestrel compliant with international quality standards.

2. How does regulatory compliance influence supplier selection?
Regulatory compliance ensures APIs and final formulations meet safety and quality standards set by agencies like the FDA and EMA. Suppliers with robust GMP certifications and prior approval histories are preferred, reducing the risk of supply disruptions and legal complications.

3. Are proprietary formulations or generic equivalents more common for Falmina?
Falmina is generally marketed as a branded contraceptive, but many generic equivalents exist, produced by various manufacturers worldwide. Generic formulations often source APIs from the same suppliers and comply with similar standards.

4. How can supply chain disruptions affect Falmina availability?
Disruptions in API production, regulatory delays, geopolitical issues, or logistical challenges can lead to shortages, impacting availability in key markets and delaying access for patients.

5. What trends could influence future suppliers for Falmina?
Growing demand for contraceptives, evolving regulations, and advancements in hormone synthesis technology may shift supplier priorities, emphasizing sustainability, cost-efficiency, and compliance.

---

References

[1] Regulatory standards and international manufacturing practices for hormonal APIs. (Source: EMA, FDA guidelines)
[2] Market analysis of API suppliers for contraceptives. (Source: IQVIA, Transparency Market Research)
[3] Global contraceptive market trends and supply chain dynamics. (Source: WHO, UNFPA reports)
[4] API manufacturer websites and quality certifications.
[5] Contract manufacturing and distribution frameworks in the pharmaceutical industry.

Note: This article synthesizes publicly available information and industry insights to provide a comprehensive overview of suppliers for Falmina.